Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 215-127-9 | CAS number: 1304-28-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Direct observations: clinical cases, poisoning incidents and other
Administrative data
- Endpoint:
- direct observations: clinical cases, poisoning incidents and other
- Type of information:
- other: case study
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- other: patient presented after purposeful ingestion of barium chloride with suicidal attempt, but due to single case occurence data can only be assessed as weight of evidence.
Data source
Reference
- Reference Type:
- publication
- Title:
- Acute Renal Failure Associated with Barium Chloride Poisoning
- Author:
- Wetherill, SF et al.
- Year:
- 1 981
- Bibliographic source:
- Annals of Internal Medicine
Materials and methods
- Study type:
- poisoning incident
- Endpoint addressed:
- acute toxicity: oral
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- Patient presented with signs of acute barium intoxication after wilfull ingestion of barium chloride with suicidal intent.
- GLP compliance:
- not specified
Test material
- Reference substance name:
- Barium chloride
- EC Number:
- 233-788-1
- EC Name:
- Barium chloride
- Cas Number:
- 10361-37-2
- IUPAC Name:
- barium dichloride
- Details on test material:
- The exact formulation of the barium chloride ingested by the patient was not provided.
Constituent 1
Method
- Type of population:
- occupational
- Subjects:
- - Number of subjects exposed: 1
- Sex: male
- Age: 52
- Race: no data
- Known diseases: alcoholic, depressed with suicidal intentions - Ethical approval:
- not applicable
- Route of exposure:
- oral
- Reason of exposure:
- intentional
- Exposure assessment:
- estimated
- Details on exposure:
- patient had ingested 1 teaspoonful of barium chloride, which was estimated to constitute about 13 mg, 8 hours prior to seeking medical attention
- Examinations:
- - Urine analysis: urinary parameters, volume
- Haematology: full blood and electrolytes - Medical treatment:
- In the 8 hours after hospitalization, patient was infused with 14 g of magnesium sulfate. In parallel, hypokalemia was treated with 240 meq potassium, given over 16 hours. Renal failure and high blood urea nitrogen as well as creatinine prompted the onset of peritoneal dialysis.
Results and discussion
- Clinical signs:
- patient was admitted with intractable diarrhea, singultus, abdominal pain, and mild weakness of the lower extremities with diminished reflexes.
- Results of examinations:
- - Urine analysis: normal at time of admission, urinary parameters dropped after administration of magnesium sulfate with occurence of urinary sediment consisting of renal tubular cells and granular casts, urinary volumes ranged from 500 ml after admission to 5000 ml on hospital day 11.
- Haematology: unremarkable upon admission, then rapid onset of hypokalemia, which increased after potassium infusion. Due to renal failure, blood urea nitrogen and creatinine drastically increased transiently.
- Lung function parameters: Lung function was impaired by progressing paralysis, finally leading to the need for mechanical ventilation
- Neurological: slight weekness in lower limbs upon hospitalization, then rapidly progressing paralysis which ascended and also affected the respiratory musculature. - Effectivity of medical treatment:
- infusion of potassium and magnesium sulfate led to a recovery of blood hypokalemia, however the parenteral administration of sulfate probably prompted the formation of insoluble barium crystals in the kidney, leading to nepthropathy.
- Outcome of incidence:
- patient recovered fully and was asymptomatic three months after discharge.
Applicant's summary and conclusion
- Executive summary:
The patient had purposefully ingested 8 mg barium chloride, which led to severe abdominal cramps with diarrhea, muscle weakness cumulating in paralysis and renal failure. During renal failure, blood pressure was increased. In conclusion, ingestion of 8 mg barium chloride results in life-threatening and potentially lethal symptoms.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.